Rocket Pharmaceuticals (NASDAQ: RCKT) reported Q1 EPS of ($0.42), $0.02 worse than the analyst estimate of ($0.40).

For earnings history and earnings-related data on Rocket Pharmaceuticals (RCKT) click here.